NCT05259189View on ClinicalTrials.gov

A Study of NBL-012 in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

May 23, 2022

Study Completion Date

May 23, 2022

Conditions
Healthy Subjects
Interventions
DRUG

NBL-012 Injection

a single subcutaneous injection

DRUG

Placebo

a single subcutaneous injection

Trial Locations (1)

215006

The First Affiliated Hospital of Soochow University., Suzhou

Sponsors
All Listed Sponsors
lead

NovaRock Biotherapeutics, Ltd

INDUSTRY

NCT05259189 - A Study of NBL-012 in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter